Hexaware Positioned as a Visionary in the 2026 Gartner® Magic Quadrant™ for Custom Software Development Services
Hexaware Positioned as a Visionary in the 2026 Gartner® Magic Quadrant™ for Custom Software Development Services
Gartner, Magic Quadrant for Custom Software Development Services, By Jaideep Thyagarajan, Ryan McKinney, Nathan Davie, 7 October 2026. Gartner and Magic Quadrant are trademarks of Gartner, Inc. and/or its affiliates. Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose. This graphic was published by Gartner, Inc. as part of a larger research document and should be evaluated in the context of the entire document. The Gartner document is available upon request from Hexaware.
Flyer
– Sixteen of the 20 largest biopharma companies are investing in cell and gene therapies.
– Hexaware’s platform supports the journey from molecule to market for personalized therapies.
– It spans clinical development, supply chain and logistics tracking, and launch commercialization.
Did you know 16 out of the 20 large biopharma companies are investing in cell and gene therapies?
Cell and gene therapy has the potential to permanently change the course of diseases like cancer and genetic disorders. Its platform involves the most complex production and delivery requirements beyond what can be achieved with generic technologies. The rapid pace of innovation and technological advances requires rapid and focused development of solutions.
Hexaware’s cell and gene therapy platform is designed to support you from molecule to market, enabling you to deliver personalized therapies to patients. Our comprehensive solutions cover the following:
With our cutting-edge technology and expert team, we can help you stay ahead of the curve by delivering cost-effective solutions and helping you navigate the complex process from research to commercialization. Read the brochure to learn more about our platform.
Download Now
Fill out the form below to gain instant access to our exclusive content